| Product Code: ETC10686319 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Israel`s import shipments of olmesartan medoxomil saw a diverse range of suppliers, with Switzerland, UK, Belgium, USA, and Germany leading the way. Despite the variety of sources, the Herfindahl-Hirschman Index (HHI) indicated low concentration in the market. The compound annual growth rate (CAGR) from 2020 to 2024 was -2.14%, reflecting a slight decline in demand over the period. The growth rate from 2023 to 2024 was -0.41%, suggesting a further decrease in import volumes. This data points to a stable yet slightly declining market for olmesartan medoxomil in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Olmesartan Medoxomil Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Olmesartan Medoxomil Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Olmesartan Medoxomil Market - Industry Life Cycle |
3.4 Israel Olmesartan Medoxomil Market - Porter's Five Forces |
3.5 Israel Olmesartan Medoxomil Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Israel Olmesartan Medoxomil Market Revenues & Volume Share, By Dosage Form, 2022 & 2032F |
3.7 Israel Olmesartan Medoxomil Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Israel Olmesartan Medoxomil Market Revenues & Volume Share, By End-Use, 2022 & 2032F |
4 Israel Olmesartan Medoxomil Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hypertension and related health conditions in Israel |
4.2.2 Growing awareness about the benefits of olmesartan medoxomil in managing hypertension |
4.2.3 Favorable government initiatives promoting the use of cardiovascular medications |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and marketing of pharmaceutical products in Israel |
4.3.2 Presence of substitute medications for treating hypertension |
4.3.3 Price fluctuations in the pharmaceutical market affecting the affordability of olmesartan medoxomil |
5 Israel Olmesartan Medoxomil Market Trends |
6 Israel Olmesartan Medoxomil Market, By Types |
6.1 Israel Olmesartan Medoxomil Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Olmesartan Medoxomil Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Israel Olmesartan Medoxomil Market Revenues & Volume, By Generic, 2022 - 2032F |
6.1.4 Israel Olmesartan Medoxomil Market Revenues & Volume, By Branded, 2022 - 2032F |
6.1.5 Israel Olmesartan Medoxomil Market Revenues & Volume, By Combinations, 2022 - 2032F |
6.1.6 Israel Olmesartan Medoxomil Market Revenues & Volume, By API, 2022 - 2032F |
6.2 Israel Olmesartan Medoxomil Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Israel Olmesartan Medoxomil Market Revenues & Volume, By Tablets, 2022 - 2032F |
6.2.3 Israel Olmesartan Medoxomil Market Revenues & Volume, By Capsules, 2022 - 2032F |
6.2.4 Israel Olmesartan Medoxomil Market Revenues & Volume, By Oral Solution, 2022 - 2032F |
6.2.5 Israel Olmesartan Medoxomil Market Revenues & Volume, By Injectable, 2022 - 2032F |
6.3 Israel Olmesartan Medoxomil Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel Olmesartan Medoxomil Market Revenues & Volume, By Hypertension, 2022 - 2032F |
6.3.3 Israel Olmesartan Medoxomil Market Revenues & Volume, By Cardiovascular Diseases, 2022 - 2032F |
6.3.4 Israel Olmesartan Medoxomil Market Revenues & Volume, By Chronic Kidney Disease, 2022 - 2032F |
6.3.5 Israel Olmesartan Medoxomil Market Revenues & Volume, By Other Cardiovascular Disorders, 2022 - 2032F |
6.4 Israel Olmesartan Medoxomil Market, By End-Use |
6.4.1 Overview and Analysis |
6.4.2 Israel Olmesartan Medoxomil Market Revenues & Volume, By Pharmaceuticals, 2022 - 2032F |
6.4.3 Israel Olmesartan Medoxomil Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.4 Israel Olmesartan Medoxomil Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.4.5 Israel Olmesartan Medoxomil Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
7 Israel Olmesartan Medoxomil Market Import-Export Trade Statistics |
7.1 Israel Olmesartan Medoxomil Market Export to Major Countries |
7.2 Israel Olmesartan Medoxomil Market Imports from Major Countries |
8 Israel Olmesartan Medoxomil Market Key Performance Indicators |
8.1 Prescription rates of olmesartan medoxomil compared to other hypertension medications |
8.2 Patient adherence and compliance rates to olmesartan medoxomil treatment regimen |
8.3 Number of healthcare professionals trained or certified in prescribing olmesartan medoxomil |
8.4 Rate of adverse events or side effects reported for olmesartan medoxomil |
8.5 Patient satisfaction and feedback on the efficacy of olmesartan medoxomil |
9 Israel Olmesartan Medoxomil Market - Opportunity Assessment |
9.1 Israel Olmesartan Medoxomil Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Israel Olmesartan Medoxomil Market Opportunity Assessment, By Dosage Form, 2022 & 2032F |
9.3 Israel Olmesartan Medoxomil Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Israel Olmesartan Medoxomil Market Opportunity Assessment, By End-Use, 2022 & 2032F |
10 Israel Olmesartan Medoxomil Market - Competitive Landscape |
10.1 Israel Olmesartan Medoxomil Market Revenue Share, By Companies, 2025 |
10.2 Israel Olmesartan Medoxomil Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here